C. Huet, A. Ouedraogo, I. Konate, I. Traore, F. Rouet et al., Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa, BMC Public Health, vol.355, issue.11, pp.700-21917177, 2011.
DOI : 10.1056/NEJMsa060247

URL : https://hal.archives-ouvertes.fr/inserm-00631427

J. Idoko, S. Meloni, M. Muazu, L. Nimzing, B. Badung et al., Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.1268-73, 2009.

M. Maskew, M. Fox, G. Van-cutsem, K. Chu, P. Macphail et al., Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study, PLoS ONE, vol.9, issue.6, p.23755122, 2013.
DOI : 10.1371/journal.pone.0064392.t003

J. Mbougua, C. Laurent, C. Kouanfack, A. Bourgeois, L. Ciaffi et al., Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon, BMC Public Health, vol.163, issue.18, p.20193053, 2010.
DOI : 10.1001/archinte.163.18.2187

E. Moore, M. Beadsworth, M. Chaponda, B. Mhango, B. Faragher et al., Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection, Journal of Infection, vol.61, issue.2, pp.155-63, 2010.
DOI : 10.1016/j.jinf.2010.04.009

F. Mosha, V. Muchunguzi, M. Matee, R. Sangeda, J. Vercauteren et al., Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania, BMC Public Health, vol.35, issue.3, pp.38-23320567, 2013.
DOI : 10.1086/341249

M. Franke, F. Kaigamba, A. Socci, M. Hakizamungu, A. Patel et al., Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.1319-1345, 2013.

J. Karasi, F. Musonera, K. Iranyumviye, J. Servais, C. Devaux et al., Assessing the WHO recommended first-line ART regimens for resource-limited settings: Comparing the relative virologic efficacy and resistance patterns of TDF/3TC/NVP to AZT/3TC/NVP in a Rwandan cohort, Journal of the International AIDS Society, vol.15, 2012.

L. Shipton, C. Wester, S. Stock, N. Ndwapi, T. Gaolathe et al., Safety and efficacy of nevirapine-and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. The international journal of tuberculosis and lung disease, the official journal of the International Union against Tuberculosis and Lung Disease, vol.1312, issue.303, pp.360-366, 2009.

A. Brennan, K. Shearer, M. Maskew, L. Long, I. Sanne et al., . tenofovir, Tropical Medicine & International Health, vol.8, issue.Suppl. 3, pp.490-498, 2014.
DOI : 10.1371/journal.pone.0064459

D. Kassa, G. Gebremichael, Y. Alemayehu, D. Wolday, T. Messele et al., Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia, AIDS Research and Therapy, vol.10, issue.1, 2013.
DOI : 10.1016/j.chom.2008.08.002

J. Igumbor, E. Scheepers, R. Ebrahim, J. A. Grimwood, and A. , An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa, AIDS Care, vol.139, issue.2, pp.231-237, 2011.
DOI : 10.1056/NEJMoa012354

C. Delaugerre, S. Gallien, P. Flandre, D. Mathez, R. Amarsy et al., Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients, PLoS ONE, vol.24, issue.5, p.22590588, 2012.
DOI : 10.1371/journal.pone.0036673.t002

J. Li, S. Gallien, T. Do, J. Martin, S. Deeks et al., Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia, Antimicrobial Agents and Chemotherapy, vol.56, issue.11, pp.5998-6000, 2012.
DOI : 10.1128/AAC.01217-12

M. Monleau, A. Aghokeng, S. Eymard-duvernay, A. Dagnra, D. Kania et al., Field Evaluation of Dried Blood Spots for Routine HIV-1 Viral Load and Drug Resistance Monitoring in Patients Receiving Antiretroviral Therapy in Africa and Asia, Journal of Clinical Microbiology, vol.52, issue.2, pp.578-86, 2014.
DOI : 10.1128/JCM.02860-13

URL : https://hal.archives-ouvertes.fr/hal-01101082

E. Rottinghaus, R. Ugbena, K. Diallo, O. Bassey, A. Azeez et al., Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.1187-9514, 2012.

A. Johannessen, Dried blood spots in HIV monitoring: applications in resource-limited settings, Bioanalysis, vol.30, issue.11, pp.1893-908, 2010.
DOI : 10.1086/650385

P. Smit, K. Sollis, S. Fiscus, N. Ford, M. Vitoria et al., Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis, e86461. PubMed Central PMCID: PMCPMC3945725. https, p.24603442, 2014.
DOI : 10.1371/journal.pone.0086461.s004

S. Aoudjane, M. Chaponda, G. D. Castillo, A. , O. Connor et al., Hepatitis B Virus Sub-genotype A1 Infection Is Characterized by High Replication Levels and Rapid Emergence of Drug Resistance in HIV-Positive Adults Receiving First-line Antiretroviral Therapy in Malawi, Clinical Infectious Diseases, vol.59, issue.11, 2014.
DOI : 10.1093/cid/ciu630

M. Maskew, A. Macphail, D. Whitby, M. Egger, and M. Fox, Kaposi Sarcoma-Associated Herpes Virus and Response to Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.63, issue.4, pp.442-450, 1999.
DOI : 10.1097/QAI.0b013e3182969cc1